UPDATE: Baxter (BAX) Sues Becton Dickinson (BDX) Over Alleged Patent Infringement
Get Alerts BAX Hot Sheet
Price: $23.49 -0.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: +2.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: +2.5%
Join SI Premium – FREE
(Updated - November 5, 2015 3:00 PM EST)
Baxter (NYSE: BAX) said to sue Becton Dickinson (NYSE: BDX) over infusion pump patent infringement, according to Bloomberg.
UPDATE - According to the report, the complaint was filed in federal court in Chicago.
The patents in question cover battery gauge, medical infusion pump, and method for automatically controlling the level of medicine.
In the suit, Baxter is seeking cash compensation and an order blocking further use of its inventions.
Shares of BDX are up 0.4 percent Thursday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond Meat ordered to pay $15.4M in trademark infringement case
- Corpay agrees to $100M FTC settlement over marketing practices
- DataMeds AI settles litigation, retiring $19M in liabilities
Create E-mail Alert Related Categories
Insiders' Blog, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share